AU671602B2 - Sparfloxacine salts and solutions containing same - Google Patents

Sparfloxacine salts and solutions containing same Download PDF

Info

Publication number
AU671602B2
AU671602B2 AU27722/92A AU2772292A AU671602B2 AU 671602 B2 AU671602 B2 AU 671602B2 AU 27722/92 A AU27722/92 A AU 27722/92A AU 2772292 A AU2772292 A AU 2772292A AU 671602 B2 AU671602 B2 AU 671602B2
Authority
AU
Australia
Prior art keywords
ligne
document
date
line
page
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU27722/92A
Other languages
English (en)
Other versions
AU2772292A (en
Inventor
Guillaume Conrath
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Rhone DPC Europe
Original Assignee
Rhone DPC Europe
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone DPC Europe filed Critical Rhone DPC Europe
Publication of AU2772292A publication Critical patent/AU2772292A/en
Application granted granted Critical
Publication of AU671602B2 publication Critical patent/AU671602B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Peptides Or Proteins (AREA)
AU27722/92A 1991-09-27 1992-09-25 Sparfloxacine salts and solutions containing same Ceased AU671602B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9111913A FR2681863B1 (fr) 1991-09-27 1991-09-27 Solution de sparfloxacine sa preparation et sel la constituant.
FR9111913 1991-09-27
PCT/FR1992/000891 WO1993005782A1 (fr) 1991-09-27 1992-09-25 Sels de sparfloxacine et solutions les contenant

Publications (2)

Publication Number Publication Date
AU2772292A AU2772292A (en) 1993-04-27
AU671602B2 true AU671602B2 (en) 1996-09-05

Family

ID=9417358

Family Applications (1)

Application Number Title Priority Date Filing Date
AU27722/92A Ceased AU671602B2 (en) 1991-09-27 1992-09-25 Sparfloxacine salts and solutions containing same

Country Status (22)

Country Link
US (1) US5478829A (enExample)
EP (2) EP0605646B1 (enExample)
JP (1) JPH07503941A (enExample)
AT (1) ATE168008T1 (enExample)
AU (1) AU671602B2 (enExample)
CA (1) CA2119270A1 (enExample)
CZ (1) CZ69494A3 (enExample)
DE (1) DE69226192D1 (enExample)
FI (1) FI941399A0 (enExample)
FR (1) FR2681863B1 (enExample)
HU (1) HUT67672A (enExample)
IL (1) IL103270A (enExample)
MX (1) MX9205461A (enExample)
NO (1) NO941036L (enExample)
NZ (1) NZ244479A (enExample)
PL (2) PL170357B1 (enExample)
SG (1) SG59982A1 (enExample)
SK (1) SK34894A3 (enExample)
TW (1) TW202393B (enExample)
WO (1) WO1993005782A1 (enExample)
YU (1) YU86792A (enExample)
ZA (1) ZA927330B (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU5103898A (en) * 1996-11-05 1998-05-29 Alcon Laboratories, Inc. Polyhydroxy monocarboxylic and dicarboxylic acids and their lactones in ophthalmic compositions
US7452545B2 (en) * 2001-11-13 2008-11-18 Yu Ruey J Oligosaccharide aldonic acids and their topical use
US6335023B1 (en) * 1999-06-30 2002-01-01 Ruey J. Yu Oligosaccharide aldonic acids and their topical use
EP1685843A1 (en) * 1999-06-30 2006-08-02 Ruey J. Dr. Yu Oligosaccharide aldonic acids and their topical use
DE19937115A1 (de) * 1999-08-06 2001-02-08 Bayer Ag Wäßrige Arzneimittelformulierung von Moxifloxacin oder Salzen davon
DE19937116A1 (de) 1999-08-06 2001-02-08 Bayer Ag Moxifloxacin Kochsalzformulierung
DE19962470A1 (de) 1999-12-22 2001-07-12 Schulz Hans Herrmann Verwendung von Chemotherapeutika
DE19962353A1 (de) 1999-12-23 2001-07-05 Henkel Ecolab Gmbh & Co Ohg Hepatitis A Viruzid
US6979471B1 (en) * 2000-09-05 2005-12-27 Council Of Scientific And Industrial Research Composition comprising pharmaceutical/nutraceutical agent and a bio-enhancer obtained from Glycyrrhiza glabra
WO2003015752A1 (en) * 2001-08-14 2003-02-27 Bakulesh Mafatlal Khamar The process for preparing isotonic topical antibiotic ophthalmic formulation with improved therapeutic effect
WO2006015545A1 (fr) * 2004-08-11 2006-02-16 Shenzhen Tys R & D Co., Ltd. Capsule de gelatine de moxifloxacin et procede pour sa preparation
TW200900066A (en) * 2007-03-22 2009-01-01 Daiichi Sankyo Co Ltd Quinolone medical composition containing alcohols
EP2712611A1 (en) 2012-09-27 2014-04-02 B. Braun Melsungen AG Stabilized aqueous compositions of neuromuscular blocking agents

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0221463A2 (en) * 1985-10-29 1987-05-13 Dainippon Pharmaceutical Co., Ltd. Quinoline derivatives and processes for preparation thereof
EP0284935A1 (de) * 1987-04-02 1988-10-05 Bayer Ag 5-Substituierte Chinolon- und Naphthyridoncarbonsäure-Derivate

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3537761A1 (de) * 1985-10-24 1987-04-30 Bayer Ag Infusionsloesungen der 1-cyclopropyl-6-fluor-1,4-dihydro-4-oxo-7- (1-piperazinyl)-chinolin-3-carbonsaeure
JPH01175935A (ja) * 1987-12-28 1989-07-12 Kyorin Pharmaceut Co Ltd 凍結乾燥注射剤

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0221463A2 (en) * 1985-10-29 1987-05-13 Dainippon Pharmaceutical Co., Ltd. Quinoline derivatives and processes for preparation thereof
EP0284935A1 (de) * 1987-04-02 1988-10-05 Bayer Ag 5-Substituierte Chinolon- und Naphthyridoncarbonsäure-Derivate

Also Published As

Publication number Publication date
US5478829A (en) 1995-12-26
HU9400868D0 (en) 1994-06-28
DE69226192D1 (de) 1998-08-13
SK34894A3 (en) 1994-08-10
IL103270A0 (en) 1993-02-21
FR2681863A1 (fr) 1993-04-02
FI941399L (fi) 1994-03-25
PL170357B1 (en) 1996-12-31
ZA927330B (en) 1993-04-21
ATE168008T1 (de) 1998-07-15
CZ69494A3 (en) 1994-07-13
SG59982A1 (en) 1999-02-22
YU86792A (sh) 1995-10-03
EP0605646B1 (fr) 1998-07-08
CA2119270A1 (fr) 1993-04-01
WO1993005782A1 (fr) 1993-04-01
NZ244479A (en) 1995-04-27
EP0534860A1 (fr) 1993-03-31
FI941399A7 (fi) 1994-03-25
AU2772292A (en) 1993-04-27
MX9205461A (es) 1993-03-01
FR2681863B1 (fr) 1995-02-03
TW202393B (enExample) 1993-03-21
NO941036D0 (no) 1994-03-22
FI941399A0 (fi) 1994-03-25
NO941036L (no) 1994-03-22
JPH07503941A (ja) 1995-04-27
HUT67672A (en) 1995-04-28
IL103270A (en) 1996-11-14
EP0605646A1 (fr) 1994-07-13
PL170495B1 (en) 1996-12-31

Similar Documents

Publication Publication Date Title
JPS6191116A (ja) 安定化された注射用ピロキシカム液剤
JPS5815909A (ja) 抗真菌外用剤
KR880002265B1 (ko) 피록시캄 1수화물의 제조 방법
CA2110119C (en) Antiinflammatory and analgesic gel preparation
AU754902B2 (en) Pharmaceutical composition for injection based on paracetamol
US5478829A (en) Solution of sparfloxacin, its preparation and salt of which it is composed
JPH10511967A (ja) エンロフロキサシンの注射用もしくは注入用溶液
JP2558279B2 (ja) 安定な水性懸濁濃厚組成物
CA1284109C (en) Aqueous solution containing a quinolone carboxylic acid
JP2751965B2 (ja) 化粧料
JPH0134968B2 (enExample)
FI95348B (fi) Menetelmä suun kautta annettavan nestemäisen koostumuksen valmistamiseksi
JPH0577648B2 (enExample)
JPH0418022A (ja) ピロキシカムの安定水溶液ならびにその製造法
CA1159367A (en) Parenteral solvent and a process for the preparation of stable solutions containing same
AU600193B2 (en) Biocidal 4,5-dichloro-1,2-dithiol-3-one composition
JPS5923292B2 (ja) γ−オリザノ−ル製剤
JPS63146817A (ja) 外用抗真菌剤
DE256461C (enExample)
JPS59190912A (ja) 消炎鎮痛クリ−ム剤
PT100098B (pt) Novos sais do acido 2-(2,6-dicloroanilino)-fenilacetico, processo para a sua preparacao e sua utilizacao em composicoes farmaceuticas para aplicacao topica
Kuhnert-Brandstätter et al. Thermomicroscopic and ultraviolet spectrophotometric identification of psychotherapeutic drugs
WO2004073680A1 (ja) 液滴分散型軟膏剤
Waugh et al. Nutrition classics
EP1046345A3 (en) Preparation for administration to animals and feeding method thereof